HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | GABA receptor ↓ ↑ | GABAA receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Niflumic Acid | ✔ | 98% | |||||||||||||||||
| Ginkgolide A |
++
GABA receptor, Ki: 14.5 μM |
98% | |||||||||||||||||
| Valproic acid sodium | ✔ | HDAC,Autophagy | 97% | ||||||||||||||||
| Flumazenil | ✔ | 95% | |||||||||||||||||
| Bemegride | ✔ | 98% | |||||||||||||||||
| Bicuculline |
+++
GABAA receptor, IC50: 2 μM |
99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Baclofen, a lipophilic derivative of γ-aminobutyric acid (GABA), is an orally active, selective metabotropic GABA-B receptor (GABABR) agonist. Baclofen has high blood brain barrier penetrance. Baclofen has the potential for muscle spasticity research[3]. Intrathecal baclofen infusion is an accepted treatment for spasticity[4]. Baclofen pretreatment (3 mg/kg) not only prolonged the time taken for animals to reach a core body temperature of 40 degrees C[5]. Moreover, repeated pretreatment attenuates baclofen-attributed neurotoxicity in overdose and results in post-discontinuation withdrawal syndrome[6]. In high-dose baclofen participants only, there was a predictive effect of lower baseline heart rate variability and fewer post-test percentage of heavy drinking days. There was a dose-specific rescuing effect of high-dose baclofen on the dynamic modulation of cardiovascular responses to eliciting cues[7]. |
| Concentration | Treated Time | Description | References | |
| Dopamine neurons in rat midbrain slices | 0.01, 0.1, 0.3, 1 μM | 10 min | Baclofen depressed the spontaneous firing rate of DA neurons in a concentration-dependent manner with an EC50 of 0.27 μM | Br J Pharmacol. 2005 Apr;144(7):926-32 |
| Administration | Dosage | Frequency | Description | References | ||
| Baboons | Alcohol self-administration model | Intramuscular injection | 0.1–1.8 mg/kg | Once daily for 5 days | To examine the effects of baclofen on alcohol seeking and self-administration when treatment was initiated during alcohol abstinence or ongoing alcohol access. Results showed that baclofen significantly reduced total alcohol intake when administered during ongoing alcohol access but not during abstinence. | Drug Alcohol Depend. 2017 Oct 1;179:47-54 |
| Female musk shrews | Postoperative nausea and vomiting model | Intraperitoneal injection | 5 mg/kg | Single dose | Baclofen eliminated emetic behaviors in the shrew PONV model | CNS Neurosci Ther. 2022 Jun;28(6):922-931 |
| Sprague-Dawley rats | Morphine-induced behavioral sensitization model | Subcutaneous injection | 1.25, 2.5, 5 mg/kg | 8 continuous days | To investigate the effects of baclofen on morphine-induced behavioral sensitization and dopamine release. Results showed that baclofen significantly inhibited morphine-induced behavioral sensitization and dopamine release. | Behav Brain Funct. 2012 Jul 10;8:20 |
| Mice | Models of anxiety-like behavior, learning, and memory | Intraperitoneal injection | 0.5, 1.5, and 2.5 mg/kg | Single administration, 30 minutes before testing | To evaluate the effects of Baclofen on anxiety-like behavior, learning, and memory in mice. Results showed that Baclofen exhibited sedation-like effects (i.e., reduced locomotor activity) at the highest dose (2.5 mg/kg) but had no significant effects on anxiety-like behavior at other doses. | Neuropharmacology. 2013 Jul;70:156-67 |
| Rats | Sprague-Dawley rats | Intraperitoneal injection | 5 mg/kg | Three times daily for five days | To evaluate the effects of acute and chronic baclofen treatments on GABA B-activated G-proteins and signaling protein phosphorylation. Results showed that chronic baclofen treatment significantly reduced GABA B-stimulated GTP γS binding and increased phosphorylation of FAK and GSK3 β. | Neuropharmacology. 2015 Aug;95:492-502 |
| Sprague-Dawley rats | Self-administration model | Intraperitoneal injection or VTA microinjection | 3 mg/kg (ip) or 50 and 100 ng/side (VTA microinjection) | Single administration, tested 20 minutes later | To investigate the effects of GABA B receptor agonist baclofen on propofol reinforcement. Results showed that baclofen significantly reduced the number of propofol self-administrations and active responses, without affecting food-maintained behavior or locomotor activity. | Acta Pharmacol Sin. 2011 Dec;32(12):1460-5 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00814632 | Vulvodynia | Phase 2 | Completed | - | United States, Michigan ... 展开 >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 收起 << |
| NCT01244113 | Cerebral Palsy | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
| NCT02771925 | Alcohol Dependence | Phase 4 | Unknown | May 2018 | India ... 展开 >> Dyanand Medical College and Hospital Recruiting Ludhiana, Punjab, India, 141001 Contact: Sandeep Singh Sidhu, MD,DM +919814025085 sandeepsidhu1963@gmail.com Contact: Omesh Goyal, MD,DM +919914821155 goyalomesh@yahoo.co.in Principal Investigator: Sandeep Singh Sidhu, MD,DM 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.68mL 0.94mL 0.47mL |
23.40mL 4.68mL 2.34mL |
46.80mL 9.36mL 4.68mL |
|
| CAS号 | 1134-47-0 |
| 分子式 | C10H12ClNO2 |
| 分子量 | 213.66 |
| SMILES Code | O=C(CC(CN)C1=CC=C(C=C1)Cl)O |
| MDL No. | MFCD00055143 |
| 别名 | 巴氯酚 ;(±)-Baclofen |
| 运输 | 蓝冰 |
| InChI Key | KPYSYYIEGFHWSV-UHFFFAOYSA-N |
| Pubchem ID | 2284 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 4 mg/mL(18.72 mM),配合低频超声,水浴加热至45℃,并调节pH至4,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 2 mg/mL(9.36 mM),配合低频超声助溶 0.1 M HCL: 10 mg/mL(46.8 mM),配合低频超声助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1